Literature DB >> 29509750

The intestinal microbiome influences checkpoint blockade.

Cynthia L Sears1, Drew M Pardoll1.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29509750      PMCID: PMC6435254          DOI: 10.1038/nm.4511

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  11 in total

1.  The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients.

Authors:  Vyara Matson; Jessica Fessler; Riyue Bao; Tara Chongsuwat; Yuanyuan Zha; Maria-Luisa Alegre; Jason J Luke; Thomas F Gajewski
Journal:  Science       Date:  2018-01-05       Impact factor: 47.728

2.  Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma.

Authors:  Jeffrey S Weber; F Stephen Hodi; Jedd D Wolchok; Suzanne L Topalian; Dirk Schadendorf; James Larkin; Mario Sznol; Georgina V Long; Hewei Li; Ian M Waxman; Joel Jiang; Caroline Robert
Journal:  J Clin Oncol       Date:  2016-11-14       Impact factor: 44.544

Review 3.  Immune checkpoint blockade: a common denominator approach to cancer therapy.

Authors:  Suzanne L Topalian; Charles G Drake; Drew M Pardoll
Journal:  Cancer Cell       Date:  2015-04-06       Impact factor: 31.743

4.  Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.

Authors:  V Gopalakrishnan; C N Spencer; L Nezi; A Reuben; M C Andrews; T V Karpinets; P A Prieto; D Vicente; K Hoffman; S C Wei; A P Cogdill; L Zhao; C W Hudgens; D S Hutchinson; T Manzo; M Petaccia de Macedo; T Cotechini; T Kumar; W S Chen; S M Reddy; R Szczepaniak Sloane; J Galloway-Pena; H Jiang; P L Chen; E J Shpall; K Rezvani; A M Alousi; R F Chemaly; S Shelburne; L M Vence; P C Okhuysen; V B Jensen; A G Swennes; F McAllister; E Marcelo Riquelme Sanchez; Y Zhang; E Le Chatelier; L Zitvogel; N Pons; J L Austin-Breneman; L E Haydu; E M Burton; J M Gardner; E Sirmans; J Hu; A J Lazar; T Tsujikawa; A Diab; H Tawbi; I C Glitza; W J Hwu; S P Patel; S E Woodman; R N Amaria; M A Davies; J E Gershenwald; P Hwu; J E Lee; J Zhang; L M Coussens; Z A Cooper; P A Futreal; C R Daniel; N J Ajami; J F Petrosino; M T Tetzlaff; P Sharma; J P Allison; R R Jenq; J A Wargo
Journal:  Science       Date:  2017-11-02       Impact factor: 47.728

5.  Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.

Authors:  Bertrand Routy; Emmanuelle Le Chatelier; Lisa Derosa; Connie P M Duong; Maryam Tidjani Alou; Romain Daillère; Aurélie Fluckiger; Meriem Messaoudene; Conrad Rauber; Maria P Roberti; Marine Fidelle; Caroline Flament; Vichnou Poirier-Colame; Paule Opolon; Christophe Klein; Kristina Iribarren; Laura Mondragón; Nicolas Jacquelot; Bo Qu; Gladys Ferrere; Céline Clémenson; Laura Mezquita; Jordi Remon Masip; Charles Naltet; Solenn Brosseau; Coureche Kaderbhai; Corentin Richard; Hira Rizvi; Florence Levenez; Nathalie Galleron; Benoit Quinquis; Nicolas Pons; Bernhard Ryffel; Véronique Minard-Colin; Patrick Gonin; Jean-Charles Soria; Eric Deutsch; Yohann Loriot; François Ghiringhelli; Gérard Zalcman; François Goldwasser; Bernard Escudier; Matthew D Hellmann; Alexander Eggermont; Didier Raoult; Laurence Albiges; Guido Kroemer; Laurence Zitvogel
Journal:  Science       Date:  2017-11-02       Impact factor: 47.728

6.  Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment.

Authors:  Noriho Iida; Amiran Dzutsev; C Andrew Stewart; Loretta Smith; Nicolas Bouladoux; Rebecca A Weingarten; Daniel A Molina; Rosalba Salcedo; Timothy Back; Sarah Cramer; Ren-Ming Dai; Hiu Kiu; Marco Cardone; Shruti Naik; Anil K Patri; Ena Wang; Francesco M Marincola; Karen M Frank; Yasmine Belkaid; Giorgio Trinchieri; Romina S Goldszmid
Journal:  Science       Date:  2013-11-22       Impact factor: 47.728

7.  The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide.

Authors:  Sophie Viaud; Fabiana Saccheri; Grégoire Mignot; Takahiro Yamazaki; Romain Daillère; Dalil Hannani; David P Enot; Christina Pfirschke; Camilla Engblom; Mikael J Pittet; Andreas Schlitzer; Florent Ginhoux; Lionel Apetoh; Elisabeth Chachaty; Paul-Louis Woerther; Gérard Eberl; Marion Bérard; Chantal Ecobichon; Dominique Clermont; Chantal Bizet; Valérie Gaboriau-Routhiau; Nadine Cerf-Bensussan; Paule Opolon; Nadia Yessaad; Eric Vivier; Bernhard Ryffel; Charles O Elson; Joël Doré; Guido Kroemer; Patricia Lepage; Ivo Gomperts Boneca; François Ghiringhelli; Laurence Zitvogel
Journal:  Science       Date:  2013-11-22       Impact factor: 47.728

8.  Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy.

Authors:  Ayelet Sivan; Leticia Corrales; Nathaniel Hubert; Jason B Williams; Keston Aquino-Michaels; Zachary M Earley; Franco W Benyamin; Yuk Man Lei; Bana Jabri; Maria-Luisa Alegre; Eugene B Chang; Thomas F Gajewski
Journal:  Science       Date:  2015-11-05       Impact factor: 47.728

9.  Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota.

Authors:  Marie Vétizou; Jonathan M Pitt; Romain Daillère; Patricia Lepage; Nadine Waldschmitt; Caroline Flament; Sylvie Rusakiewicz; Bertrand Routy; Maria P Roberti; Connie P M Duong; Vichnou Poirier-Colame; Antoine Roux; Sonia Becharef; Silvia Formenti; Encouse Golden; Sascha Cording; Gerard Eberl; Andreas Schlitzer; Florent Ginhoux; Sridhar Mani; Takahiro Yamazaki; Nicolas Jacquelot; David P Enot; Marion Bérard; Jérôme Nigou; Paule Opolon; Alexander Eggermont; Paul-Louis Woerther; Elisabeth Chachaty; Nathalie Chaput; Caroline Robert; Christina Mateus; Guido Kroemer; Didier Raoult; Ivo Gomperts Boneca; Franck Carbonnel; Mathias Chamaillard; Laurence Zitvogel
Journal:  Science       Date:  2015-11-05       Impact factor: 47.728

10.  Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab.

Authors:  N Chaput; P Lepage; C Coutzac; E Soularue; K Le Roux; C Monot; L Boselli; E Routier; L Cassard; M Collins; T Vaysse; L Marthey; A Eggermont; V Asvatourian; E Lanoy; C Mateus; C Robert; F Carbonnel
Journal:  Ann Oncol       Date:  2017-06-01       Impact factor: 32.976

View more
  20 in total

Review 1.  Expression, prognostic significance and therapeutic implications of PD-L1 in gliomas.

Authors:  Gayaththri Vimalathas; Bjarne Winther Kristensen
Journal:  Neuropathol Appl Neurobiol       Date:  2021-10-20       Impact factor: 6.250

Review 2.  The Gut Microbiome in Pancreatic Disease.

Authors:  Venkata S Akshintala; Rupjyoti Talukdar; Vikesh K Singh; Michael Goggins
Journal:  Clin Gastroenterol Hepatol       Date:  2018-08-23       Impact factor: 11.382

3.  Patient-derived cancer modeling for precision medicine in colorectal cancer: beyond the cancer cell line.

Authors:  Dae Hee Pyo; Hye Kyung Hong; Woo Yong Lee; Yong Beom Cho
Journal:  Cancer Biol Ther       Date:  2020-03-25       Impact factor: 4.742

4.  The Amount of Bifidobacterium Genus in Colorectal Carcinoma Tissue in Relation to Tumor Characteristics and Clinical Outcome.

Authors:  Keisuke Kosumi; Tsuyoshi Hamada; Hideo Koh; Jennifer Borowsky; Susan Bullman; Tyler S Twombly; Daniel Nevo; Yohei Masugi; Li Liu; Annacarolina da Silva; Yang Chen; Chunxia Du; Mancang Gu; Chenxi Li; Wanwan Li; Hongli Liu; Yan Shi; Kosuke Mima; Mingyang Song; Katsuhiko Nosho; Jonathan A Nowak; Reiko Nishihara; Hideo Baba; Xuehong Zhang; Kana Wu; Molin Wang; Curtis Huttenhower; Wendy S Garrett; Matthew L Meyerson; Jochen K Lennerz; Marios Giannakis; Andrew T Chan; Jeffrey A Meyerhardt; Charles S Fuchs; Shuji Ogino
Journal:  Am J Pathol       Date:  2018-09-20       Impact factor: 4.307

5.  Checkpoint Blockade: Not Yet NINJA Status in Ovarian Cancer.

Authors:  Rebecca L Porter; Ursula A Matulonis
Journal:  J Clin Oncol       Date:  2021-09-16       Impact factor: 44.544

6.  Microbiota regulate innate immune signaling and protective immunity against cancer.

Authors:  Changsheng Xing; Mingjun Wang; Adebusola A Ajibade; Peng Tan; Chuntang Fu; Lang Chen; Motao Zhu; Zhao-Zhe Hao; Junjun Chu; Xiao Yu; Bingnan Yin; Jiahui Zhu; Wan-Jou Shen; Tianhao Duan; Helen Y Wang; Rong-Fu Wang
Journal:  Cell Host Microbe       Date:  2021-04-23       Impact factor: 31.316

7.  Association of Fusobacterium nucleatum with Specific T-cell Subsets in the Colorectal Carcinoma Microenvironment.

Authors:  Jennifer Borowsky; Koichiro Haruki; Mai Chan Lau; Andressa Dias Costa; Jochen K Lennerz; Marios Giannakis; Jonathan A Nowak; Shuji Ogino; Juha P Väyrynen; Tomotaka Ugai; Kota Arima; Annacarolina da Silva; Kristen D Felt; Melissa Zhao; Carino Gurjao; Tyler S Twombly; Kenji Fujiyoshi; Sara A Väyrynen; Tsuyoshi Hamada; Kosuke Mima; Susan Bullman; Tabitha A Harrison; Amanda I Phipps; Ulrike Peters; Kimmie Ng; Jeffrey A Meyerhardt; Mingyang Song; Edward L Giovannucci; Kana Wu; Xuehong Zhang; Gordon J Freeman; Curtis Huttenhower; Wendy S Garrett; Andrew T Chan; Barbara A Leggett; Vicki L J Whitehall; Neal Walker; Ian Brown; Mark Bettington; Reiko Nishihara; Charles S Fuchs
Journal:  Clin Cancer Res       Date:  2021-02-25       Impact factor: 13.801

8.  A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors.

Authors:  Fyza Y Shaikh; James R White; Joell J Gills; Taiki Hakozaki; Corentin Richard; Bertrand Routy; Yusuke Okuma; Mykhaylo Usyk; Abhishek Pandey; Jeffrey S Weber; Jiyoung Ahn; Evan J Lipson; Jarushka Naidoo; Drew M Pardoll; Cynthia L Sears
Journal:  Clin Cancer Res       Date:  2021-02-16       Impact factor: 13.801

Review 9.  Intestinal microbiota: a new force in cancer immunotherapy.

Authors:  Zhujiang Dai; Jingqiu Zhang; Qi Wu; Huiwen Fang; Chunfeng Shi; Zhen Li; Chaobiao Lin; Dong Tang; Daorong Wang
Journal:  Cell Commun Signal       Date:  2020-06-10       Impact factor: 5.712

Review 10.  Role of the intestinal microbiome and microbial-derived metabolites in immune checkpoint blockade immunotherapy of cancer.

Authors:  Eiko Hayase; Robert R Jenq
Journal:  Genome Med       Date:  2021-06-23       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.